Trilogy Capital’s iShares Morningstar Mid-Cap Growth ETF IMCG Stock Holding History
Bought
Maintained
Sold
Other funds holding IMCG
VIA
RWM
AFG
Trilogy Capital's IMCG Position: Q2 2026 in Review
Trilogy Capital reduced its iShares Morningstar Mid-Cap Growth ETF (IMCG) stake by 1% in Q2 2026, selling an estimated $3.43K and leaving 3,614 shares worth $355K. The position accounts for 0.01% of the portfolio, ranked #312.
Trilogy Capital first reported a position in IMCG in Q2 2025 and has held it in 5 quarters since. The position peaked at $635K in Q3 2025. 423 funds tracked by Wall St. Rank hold IMCG as of Q2 2026.
- Trilogy Capital held 3,614 shares of iShares Morningstar Mid-Cap Growth ETF worth $355K as of Q2 2026.
- Trilogy Capital sold 38 iShares Morningstar Mid-Cap Growth ETF shares in Q2 2026, an estimated $3.43K.
- iShares Morningstar Mid-Cap Growth ETF made up 0.01% of Trilogy Capital's portfolio in Q2 2026, its #312 holding.
- Trilogy Capital first reported a position in iShares Morningstar Mid-Cap Growth ETF in Q2 2025 and has held it in 5 quarters since.
- Trilogy Capital's iShares Morningstar Mid-Cap Growth ETF position peaked at $635K in Q3 2025.
- 423 funds tracked by Wall St. Rank held iShares Morningstar Mid-Cap Growth ETF as of Q2 2026.
Based on Trilogy Capital's 13F filing for Q2 2026, filed 6 Jul 2026.